Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-24,424
Closed -$236K 440
2024
Q4
$236K Buy
24,424
+4,404
+22% +$45.7K 0.01% 322
2024
Q3
$239K Buy
20,020
+1,860
+10% +$26.3K 0.01% 379
2024
Q2
$291K Buy
18,160
+444
+3% +$6.86K 0.01% 399
2024
Q1
$208K Sell
17,716
-5,967
-25% -$84.3K 0.01% 398
2023
Q4
$423K Sell
23,683
-22,069
-48% -$324K 0.01% 368
2023
Q3
$835K Sell
45,752
-2,500
-5% -$59.7K 0.01% 351
2023
Q2
$1.14M Sell
48,252
-24,957
-34% -$583K 0.02% 369
2023
Q1
$1.76M Buy
+73,209
New +$973K 0.04% 342
2022
Q4
Sell
-66,959
Closed -$1.29M 272
2022
Q3
$1.29M Buy
66,959
+3,679
+6% +$71.9K 0.01% 713
2022
Q2
$942K Buy
+63,280
New +$1.22M 0.01% 775
2016
Q3
Sell
-3,125
Closed -$542K 481
2016
Q2
$542K Buy
+3,125
New +$884K 0.01% 337

Other funds holding SCYX

UBS O'Connor's SCYX Position: Q1 2025 in Review

UBS O'Connor sold out of SCYNEXIS (SCYX) in Q1 2025, closing a stake of 24,424 shares — an estimated $236K sold.

UBS O'Connor first reported a position in SCYX in Q2 2016 and held it in 11 quarters. The position peaked at $1.76M in Q1 2023. 41 funds tracked by Wall St. Rank hold SCYX as of Q1 2025.

  • UBS O'Connor reported no remaining SCYNEXIS position as of Q1 2025 after selling out during the quarter.
  • UBS O'Connor sold 24,424 SCYNEXIS shares in Q1 2025, an estimated $236K.
  • UBS O'Connor first reported a position in SCYNEXIS in Q2 2016 and held it in 11 quarters.
  • UBS O'Connor's SCYNEXIS position peaked at $1.76M in Q1 2023.
  • 41 funds tracked by Wall St. Rank held SCYNEXIS as of Q1 2025.

Based on UBS O'Connor's 13F filing for Q1 2025, filed 15 May 2025.